Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers
收藏NIAID Data Ecosystem2026-03-08 收录
官方服务：
资源简介：
This is what the FFCD 11-01 - PRODIGE 25 trial proposes to study, as a preliminary for strategic studies evaluating the usefulness of including targeted therapeutics from the first line with aflibercept +/- LV5FU2.
创建时间：
2015-05-15
